Jefferies initiated coverage of Acuren (TIC) with a Buy rating and $16 price target The company is positioned to boost EBITDA margins due to cost synergies from the NV5 acquisition, operating leverage, and business improvements, the analyst tells investors in a research note. The firm views Acuren’s $20M NV5 cost synergy target as conservative.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TIC: